EZH2 and renal carcinoma: Subsequently, Hirata et al. (2015) also reported that MALAT-1 was highly expressed in renal cancer tissues and the high expression of MALAT-1 could promote the expression of EZH2, thus promoting tumor epithelial-to-mesenchymal transition (EMT) and further promoting the progression of renal cancer.